Determination of variation parameters as a crucial step in designing TMT-based clinical proteomics experiments

PLoS ONE

Volumn 10, Issue 3, 2015, Pages

  Maes, Evelyne ^a,b,c   Valkenborg, Dirk ^a,b,d   Baggerman, Geert ^a,b   Willems, Hanny ^a,b   Landuyt, Bart ^c   Schoofs, Liliane ^c   Mertens, Inge ^a,b  

^a FLEMISH INSTITUTE FOR TECHNOLOGICAL RESEARCH VITO   (Belgium)

^b UNIVERSITY OF ANTWERP   (Belgium)

^c UNIVERSITY OF LEUVEN   (Belgium)

^d HASSELT UNIVERSITY   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN VARIANT; PROTEOME; PEPTIDE;

ADULT; ARTICLE; CELL ASSAY; CELL FRACTIONATION; CELL ISOLATION; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN CELL; LIQUID CHROMATOGRAPHY; MALE; PERIPHERAL BLOOD MONONUCLEAR CELL; PROTEIN DETERMINATION; PROTEIN STRUCTURE; QUANTITATIVE ANALYSIS; REPRODUCIBILITY; STRUCTURAL PROTEOMICS; TANDEM MASS SPECTROMETRY; TANDEM MASS TAG; CLUSTER ANALYSIS; METABOLISM; MIDDLE AGED; MONONUCLEAR CELL; PILOT STUDY; PROCEDURES; PROTEOMICS; STANDARDS;

CLUSTER ANALYSIS; FEMALE; HUMANS; LEUKOCYTES, MONONUCLEAR; MALE; MIDDLE AGED; PEPTIDES; PILOT PROJECTS; PROTEOME; PROTEOMICS; TANDEM MASS SPECTROMETRY;

EID: 84925280133     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0120115     Document Type: Article

References (35)

1. Zhang Y, Fonslow BR, Shan B, Baek MC, Yates JR III (2013) Protein analysis by shotgun/bottom-up proteomics. Chem Rev 113: 2343-2394. doi: 10.1021/cr3003533 PMID: 23438204
2. Wu Q, Yuan H, Zhang L, Zhang Y (2012) Recent advances on multidimensional liquid chromatogra-phy-mass spectrometry for proteomics: from qualitative to quantitative analysis-a review. Anal Chim Acta 731: 1-10. S0003-2670(12)00559-4 [pii]; doi: 10.1016/j.aca.2012.04.010 PMID: 22652259
3. Levin Y (2011) The role of statistical power analysis in quantitative proteomics. Proteomics 11: 2565-2567. doi: 10.1002/pmic.201100033 PMID: 21591257
4. Li Z, Adams RM, Chourey K, Hurst GB, Hettich RL, Pan C (2012) Systematic comparison of label-free, metabolic labeling, and isobaric chemical labeling for quantitative proteomics on LTQ Orbitrap Velos. J Proteome Res 11: 1582-1590. doi: 10.1021/pr200748h PMID: 22188275
5. Dayon L, Hainard A, Licker V, Turck N, Kuhn K, Hochstrasser DF, et al. (2008) Relative quantification of proteins in human cerebrospinal fluids by MS/MS using 6-plex isobaric tags. Anal Chem 80: 2921-2931. doi: 10.1021/ac702422x PMID: 18312001
6. Christoforou AL, Lilley KS (2012) Isobaric tagging approaches in quantitative proteomics: the ups and downs. Anal Bioanal Chem 404: 1029-1037. doi: 10.1007/s00216-012-6012-9 PMID: 22580419
7. Karp NA, Huber W, Sadowski PG, Charles PD, Hester SV, Lilley KS (2010) Addressing accuracy and precision issues in iTRAQ quantitation. Mol Cell Proteomics 9: 1885-1897. M900628-MCP200 [pii]; doi: 10.1074/mcp.M900628-MCP200 PMID: 20382981
8. Mesko B, Poliska S, Nagy L (2011) Gene expression profiles in peripheral blood for the diagnosis of autoimmune diseases. Trends Mol Med 17: 223-233. S1471-4914(10)00190-5 [pii]; doi: 10.1016/j. molmed.2010.12.004 PMID: 21388884
9. Dotzlaw H, Schulz M, Eggert M, Neeck G (2004) A pattern of protein expression in peripheral blood mononuclear cells distinguishes rheumatoid arthritis patients from healthy individuals. Biochim Biophys Acta 1696: 121-129. S1570963903002978 [pii]. PMID: 14726212
10. Maes E, Landuyt B, Mertens I, Schoofs L (2013) Interindividual variation in the proteome of human peripheral blood mononuclear cells. PLoS One 8: e61933. PONE-D-12-26830 [pii]. doi: 10.1371/journal. pone.0061933 PMID: 23613975
11. Wang L, Dai Y, Qi S, Sun B, Wen J, Zhang L, et al. (2012) Comparative proteome analysis of peripheral blood mononuclear cells in systemic lupus erythematosus with iTRAQ quantitative proteomics. Rheumatol Int 32: 585-593. doi: 10.1007/s00296-010-1625-9 PMID: 21120503
12. Vergara D, Chiriaco F, Acierno R, Maffia M (2008) Proteomic map of peripheral blood mononuclear cells. Proteomics 8: 2045-2051. doi: 10.1002/pmic.200700726 PMID: 18491318
13. Cigna D, D'Anna C, Zizzo C, Francofonte D, Sorrentino I, Colomba P, et al. (2013) Alteration of proteomic profiles in PBMC isolated from patients with Fabry disease: preliminary findings. Mol Biosyst 9: 1162-1168. doi: 10.1039/c3mb25402j PMID: 23385635
14. Dayon L, Pasquarello C, Hoogland C, Sanchez JC, Scherl A (2010) Combining low- and high-energy tandem mass spectra for optimized peptide quantification with isobaric tags. J Proteomics 73: 769-777. S1874-3919(09)00328-5 [pii]; doi: 10.1016/j.jprot.2009.10.015 PMID: 19903544
15. Kocher T, Pichler P, Schutzbier M, Stingl C, Kaul A, Teucher N, et al. (2009) High precision quantitative proteomics using iTRAQ on an LTQ Orbitrap: a new mass spectrometric method combining the benefits of all. J Proteome Res 8: 4743-4752. doi: 10.1021/pr900451u PMID: 19663507
16. Nesvizhskii AI, Vitek O, Aebersold R (2007) Analysis and validation of proteomic data generated by tandem mass spectrometry. Nat Methods 4: 787-797. nmeth1088 [pii]; doi: 10.1038/nmeth1088 PMID: 17901868
17. Ejigu BA, Valkenborg D, Baggerman G, Vanaerschot M, Witters E, Dujardin JC, et al. (2013) Evaluation of normalization methods to pave the way towards large-scale LC-MS-based metabolomics profiling experiments. OMICS 17: 473-485. doi: 10.1089/omi.2013.0010 PMID: 23808607
18. Wei C, Li J, Bumgarner RE (2004) Sample size for detecting differentially expressed genes in microarray experiments. BMC Genomics 5: 87. 1471-2164-5-87 [pii]; doi: 10.1186/1471-2164-5-87 PMID: 15533245
19. Wu L, Candille SI, Choi Y, Xie D, Jiang L, Li-Pook-Than J, et al. (2013) Variation and genetic control of protein abundance in humans. Nature 499: 79-82. nature12223 [pii]; doi: 10.1038/nature12223 PMID: 23676674
20. Ow SY, Salim M, Noirel J, Evans C, Rehman I, Wright PC (2009) iTRAQ underestimation in simple and complex mixtures: "the good, the bad and the ugly". J Proteome Res 8: 5347-5355. doi: 10.1021/ pr900634c PMID: 19754192
21. Ting L, Rad R, Gygi SP, HaasW(2011) MS3 eliminates ratio distortion in isobaric multiplexed quantitative proteomics. Nat Methods 8: 937-940. nmeth.1714 [pii]; doi: 10.1038/nmeth.1714 PMID: 21963607
22. Corzett TH, Fodor IK, Choi MW, Walsworth VL, Chromy BA, Turteltaub KW, et al. (2006) Statistical analysis of the experimental variation in the proteomic characterization of human plasma by two-dimensional difference gel electrophoresis. J Proteome Res 5: 2611-2619. doi: 10.1021/pr060100p PMID: 17022632
23. Winkler W, Zellner M, Diestinger M, Babeluk R, Marchetti M, Goll A, et al. (2008) Biological variation of the platelet proteome in the elderly population and its implication for biomarker research. Mol Cell Proteomics 7: 193-203. M700137-MCP200 [pii]; doi: 10.1074/mcp.M700137-MCP200 PMID: 17962630
24. Zhang X, Guo Y, Song Y, Sun W, Yu C, Zhao X, et al. (2006) Proteomic analysis of individual variation in normal livers of human beings using difference gel electrophoresis. Proteomics 6: 5260-5268. doi: 10.1002/pmic.200600006 PMID: 16947120
25. Gan CS, Chong PK, Pham TK, Wright PC (2007) Technical, experimental, and biological variations in isobaric tags for relative and absolute quantitation (iTRAQ). J Proteome Res 6: 821-827. doi: 10.1021/ pr060474i PMID: 17269738
26. Song X, Bandow J, Sherman J, Baker JD, Brown PW, McDowell MT, et al. (2008) iTRAQ experimental design for plasma biomarker discovery. J Proteome Res 7: 2952-2958. doi: 10.1021/pr800072x PMID: 18549257
27. Zhou C, Simpson KL, Lancashire LJ, Walker MJ, Dawson MJ, Unwin RD, et al. (2012) Statistical considerations of optimal study design for human plasma proteomics and biomarker discovery. J Proteome Res 11: 2103-2113. doi: 10.1021/pr200636x PMID: 22338609
28. Nagaraj N, MannM (2011) Quantitative analysis of the intra- and inter-individual variability of the normal urinary proteome. J Proteome Res 10: 637-645. doi: 10.1021/pr100835s PMID: 21126025
29. Piehowski PD, Petyuk VA, Orton DJ, Xie F, Moore RJ, Ramirez-Restrepo M, et al. (2013) Sources of technical variability in quantitative LC-MS proteomics: human brain tissue sample analysis. J Proteome Res 12: 2128-2137. doi: 10.1021/pr301146m PMID: 23495885
30. Perrin RJ, Payton JE, Malone JP, Gilmore P, Davis AE, Xiong C, et al. (2013) Quantitative label-free proteomics for discovery of biomarkers in cerebrospinal fluid: assessment of technical and inter-individual variation. PLoS One 8: e64314. PONE-D-13-07682 [pii]. doi: 10.1371/journal.pone.0064314 PMID: 23700471
31. Russell MR, Lilley KS (2012) Pipeline to assess the greatest source of technical variance in quantitative proteomics using metabolic labelling. J Proteomics 77: 441-454. S1874-3919(12)00664-1 [pii]; doi: 10.1016/j.jprot.2012.09.020 PMID: 23079070
32. Skates SJ, Gillette MA, Labaer J, Carr SA, Anderson L, Liebler DC, et al. (2013) Statistical Design for Biospecimen Cohort Size in Proteomics-based Biomarker Discovery and Verification Studies. J Proteome Res. doi: 10.1021/pr400132j
33. Paulovich AG, Whiteaker JR, Hoofnagle AN, Wang P (2008) The interface between biomarker discovery and clinical validation: The tar pit of the protein biomarker pipeline. Proteomics Clin Appl 2: 1386-1402. doi: 10.1002/prca.200780174 PMID: 20976028
34. Zolg JW, Langen H (2004) How industry is approaching the search for new diagnostic markers and biomarkers. Mol Cell Proteomics 3: 345-354. M400007-MCP200 [pii]. doi: 10.1074/mcp.M400007-MCP200 PMID: 14749446
35. Whiteaker JR, Lin C, Kennedy J, Hou L, Trute M, Sokal I, et al. (2011) A targeted proteomics-based pipeline for verification of biomarkers in plasma. Nat Biotechnol 29: 625-634. nbt.1900 [pii]; doi: 10. 1038/nbt.1900 PMID: 21685906